Evidence map›Paper›PMID 26373539›Full record

ArticleSchizophrenia bulletin2016

Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia.

Karin E Borgmann-Winter, Hoau-Yan Wang, Rabindranath Ray, Brooke R Willis, Paul J Moberg, Nancy E Rawson, Raquel E Gur, Bruce I Turetsky, Chang-Gyu Hahn

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Organoid models for chemosensing cell studies.American journal of physiology. Cell physiology · 2025
    Review
  2. Article
  3. Article
  4. Unraveling the Link between Olfactory Deficits and Neuropsychiatric Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  5. Article
  6. Article
  7. Characterization of dopamine DPharmacological reports : PR · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Karin E Borgmann-WinterDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA; Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA;
Hoau-Yan WangDepartment of Physiology, Pharmacology and Neuroscience, City University of New York Medical School, New York, NY;
Rabindranath RayDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA;
Brooke R WillisDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA;
Paul J MobergDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA;
Nancy E RawsonAFB International, 3 Research Park Drive, St. Charles, MO.
Raquel E GurDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA;
Bruce I TuretskyDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA;
Chang-Gyu HahnDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA; hahnc@mail.med.upenn.edu.
University of Pennsylvania · USChildren's Hospital of Philadelphia · USCUNY School of Law · US

Funding

Olfactory Evoked Potentials and Developmental Neuropathology in SchizophreniaR01MH059852 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI HAHN, CHANG-GYU, TURETSKY, BRUCE I · 1999 to 2015
$6.6M
Neuroprotective/Neurodevelopmental Effects-Antipsychotics in Adolescent PsychosesK23MH079498 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI BORGMANN-WINTER, KARIN · 2010 to 2014
$819k
NIMH NIH HHS K23MH079498NIMH NIH HHS R01 MH059852NIMH NIH HHS R01MH059852
6 · The paper itself

Abstract

Increasing evidence suggests that olfactory dysfunction is an endophenotype of schizophrenia, and thus the olfactory system can be studied both in relation to this sensory dysfunction and also as a means of examining pathophysiologic mechanisms of schizophrenia. In this study, we examined human olfactory neuroepithelial (ON) biopsy tissues and their in vitro culture cells for ligand-induced guanine nucleotide-binding protein (G protein) activation and downstream signaling. We assessed the binding of a nonhydrolyzable GTP analogue [(35)S]GTPγS binding to specific G protein subtypes in response to odorants, dopamine, or serotonin in ON cell membranes from matched schizophrenia-control subjects. In response to odorant mixtures, we found decreased [(35)S]GTPγS binding to Gαs/olf in schizophrenia patients. These changes were not mediated by mRNA expression of key molecules of G protein coupling, including adenylate cyclase III (ACIII), protein kinase A (PKA), protein kinase Cγ (PKCγ), or Gαs or Gαolf in ON cells or ON biopsy tissues. In contrast, dopamine (DA)- and serotonin (5HT)-induced S(35)-GTPγS binding to Gαs/olf and Gαq/11 were significantly increased in schizophrenia cases, while these parameters were strikingly reduced by in vitro treatment with antipsychotics. Patients with schizophrenia exhibit increases in electrolfactogram (EOG) recordings, suggesting enhanced odorant-induced activation. Our results of decreased odorant-induced G protein activation may point further downstream for underlying mechanisms for increased EOG measures. Increased G protein activation in response to DA and 5HT may suggest increased postreceptor DA or 5HT signaling as an additional mechanism of dopaminergic or serotonergic dysregulation in schizophrenia.

Indexed as

AdultCells, CulturedFemaleGTP-Binding Protein alpha SubunitsGuanosine 5'-O-(3-Thiotriphosphate)HumansMaleMiddle AgedNasal SeptumNeuroepithelial CellsOlfaction DisordersSchizophreniaSignal TransductionTurbinatesGTP-Binding Protein alpha SubunitsGuanosine 5'-O-(3-Thiotriphosphate)olfactory G protein subunit alpha olfdopamineG proteinolfactoryschizophreniaserotonin

Identifiers

PMID26373539
PMCPMC4753598
OpenAlexW2279522886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.